Xavier Bantreil

Title: Xavier Bantreil: Innovator in Pyrroloquinoline Derivatives

Introduction

Xavier Bantreil is a notable inventor based in Aigues-Vives, France. He has made significant contributions to the field of pharmacology, particularly through his innovative work on pyrroloquinoline derivatives. His research focuses on developing compounds that serve as antagonists of 5-HT6 receptors, which have potential therapeutic applications for various mental health disorders.

Latest Patents

Xavier Bantreil holds 1 patent related to his invention concerning pyrroloquinoline derivatives. This invention details methods for the preparation of these compounds and introduces novel intermediates useful for their synthesis. The compounds are designed for therapeutic use in treating conditions such as schizophrenia, anxiety, depression, and several other mood and cognitive disorders. The general formula of these compounds is specified in the patent description, highlighting their diverse applications in medicine.

Career Highlights

Throughout his career, Xavier Bantreil has worked with esteemed institutions, including Jagiellonian University and the Institute of Pharmacology of the Polish Academy of Sciences. His work has contributed to advancing the understanding of pharmacological treatments and their applications in various health conditions.

Collaborations

Xavier has collaborated with notable colleagues such as Pawel Zajdel and Katarzyna Grychowska. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of pharmacology.

Conclusion

Xavier Bantreil's contributions to the development of pyrroloquinoline derivatives mark a significant advancement in pharmacological research. His innovative work holds promise for improving therapeutic options for a range of mental health disorders.